Sarah Olelewe, M.D.
Dr. Sarah Olelewe received her medical degree from the University of Calabar Faculty of Medicine and is board-certified in Internal Medicine and Geriatric Medicine. She spent her residency at the Charles R. Drew University of Medicine and Science, where she gained expertise in Internal Medicine. Dr. Sarah Olelewe's fellowship at the UCLA Medical Center allowed her to gain experience in the field of Geriatric Medicine. She is qualified to treat conditions related to aging, specializing in both common illnesses and complex medical problems. Her expertise has gained her the Meaningful Use Stage 1 Certification. The physician has over 30 years of professional experience. Dr. Sarah Olelewe was part of multiple clinical trials, including The Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients (INSIGHT), A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia, and The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility.
Conditions Dr. Sarah Olelewe Treats at Cedars-Sinai Marina del Rey Hospital
- Blue Cross / Blue Shield
- Blue Cross of California
- Blue Shield of California
- Coventry Health Care
- United Healthcare
Education & Training
University of Calabar Faculty of Medicine
Charles R. Drew University of Medicine and Science Residency, Internal Medicine
UCLA Medical Center Fellowship, Geriatric Medicine